Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 397

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas

Castro-Vega, Luis Jaime, Buffet, Alexandre, De Cubas, Aguirre A., Cascón, Alberto, Menara, Mélanie, Khalifa, Emmanuel, Amar, Laurence, Azriel, Sharona, Bourdeau, Isabelle, Chabre, Olivier, Currás-Freixes, Maria, Franco-Vidal, Valérie, Guillaud-Bataille, Marine, Simian, Christophe, Morin, Aurélie, Letón, Rocío, Gómez-Graña, Álvaro, Pollard, Patrick J., Rustin, Pierre, Robledo, Mercedes, Favier, Judith, Gimenez-Roqueplo, Anne-Paule·2014·Human Molecular Genetics

Abstract

Malignant pheochromocytoma (PCC) and paraganglioma (PGL) are mostly caused by germline mutations of SDHB, encoding a subunit of succinate dehydrogenase. Using whole-exome sequencing, we recently identified a mutation in the FH gene encoding fumarate hydratase, in a PCC with an 'SDH-like' molecular phenotype. Here, we investigated the role of FH in PCC/PGL predisposition, by screening for germline FH mutations in a large international cohort of patients. We screened 598 patients with PCC/PGL without mutations in known PCC/PGL susceptibility genes. We searched for FH germline mutations and large deletions, by direct sequencing and multiplex ligation-dependent probe amplification methods. Global alterations in DNA methylation and protein succination were assessed by immunohistochemical staining for 5-hydroxymethylcytosine (5-hmC) and S-(2-succinyl) cysteine (2SC), respectively. We identified five pathogenic germline FH mutations (four missense and one splice mutation) in five patients. Somatic inactivation of the second allele, resulting in a loss of fumarate hydratase activity, was demonstrated in tumors with FH mutations. Low tumor levels of 5-hmC, resembling those in SDHB-deficient tumors, and positive 2SC staining were detected in tumors with FH mutations. Clinically, metastatic phenotype (P = 0.007) and multiple tumors (P = 0.02) were significantly more frequent in patients with FH mutations than those without such mutations. This study reveals a new role for FH in susceptibility to malignant and/or multiple PCC/PGL. Remarkably, FH-deficient PCC/PGLs display the same pattern of epigenetic deregulation as SDHB-mutated malignant PCC/PGL. Therefore, we propose that mutation screening for FH should be included in PCC/PGL genetic testing, at least for tumors with malignant behavior.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddt639

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 397

Metadata

Authors
Castro-Vega, L. J., Buffet, A., De Cubas, A. A., Cascón, A., Menara, M., Khalifa, E., Amar, L., Azriel, S., Bourdeau, I., Chabre, O., Currás-Freixes, M., Franco-Vidal, V., Guillaud-Bataille, M., Simian, C., Morin, A., Letón, R., Gómez-Graña, Á., Pollard, P. J., Rustin, P., Robledo, M., Favier, J., & Gimenez-Roqueplo, A.-P.
Venue
Human Molecular Genetics
Published
2013-12-13
Volume
23
Issue
9
Pages
2440-2446
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2170005108
Cited by
397
References
27
FWCI
27.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. https://app.cochat.ai/papers/10.1093/hmg/ddt639
The paper
Castro-Vega, L. J., Buffet, A., De Cubas, A. A., Cascón, A., Menara, M., Khalifa, E., Amar, L., Azriel, S., Bourdeau, I., Chabre, O., Currás-Freixes, M., Franco-Vidal, V., Guillaud-Bataille, M., Simian, C., Morin, A., Letón, R., Gómez-Graña, Á., Pollard, P. J., Rustin, P., . . . Gimenez-Roqueplo, A.-P. (2014). Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddt639

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.